Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Diabetes mellitus4971 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A14331 | 29463026 | Nutrients | The Nile Rat (Arvicanthis niloticus) as a Superior Carbohydrate-Sensitive Model for Type 2 Diabetes Mellitus (T2DM). | 2018 | Details |
| A14337 | 29461236 | Georgian Med News | FEATURES OF EXCRETION OF MELATONIN IN URINE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND NON-ALCOHOLIC FATTY LIVER DISEASE WITH MANIFESTATIONS OF FIBROSIS AND ITS RELATIONSHIP WITH CERTAIN METABOLIC AND IMMUNOLOGICAL INDICATORS. | 2018 | Details |
| A14340 | 29456698 | Exp Ther Med | Correlation of blood glucose, serum chemerin and insulin resistance with NAFLD in patients with type 2 diabetes mellitus. | 2018 | Details |
| A14341 | 29456675 | Exp Ther Med | Correlation between PPAR-α methylation level in peripheral blood and atherosclerosis of NAFLD patients with DM. | 2018 | Details |
| A14361 | 29447962 | Int J Biol Macromol | Low molecular weight fucoidan attenuates liver injury via SIRT1/AMPK/PGC1α axis in db/db mice. | 2018 | Details |
| A14380 | 29437160 | Int J Obes (Lond) | Protective effect of black relative to white race against non-alcoholic fatty liver disease in patients with severe obesity, independent of type 2 diabetes. | 2017 | Details |
| A14382 | 29434731 | Exp Ther Med | Correlation between PPAR-α methylation level in peripheral blood and inflammatory factors of NAFLD patients with DM. | 2017 | Details |
| A14386 | 29432700 | J Int Med Res | Relationship between diverticulosis and nonalcoholic fatty liver disease in elderly patients. | 2018 | Details |
| A14387 | 29432207 | J Pediatr Endocrinol Metab | Prevalence of comorbid conditions pre-existing and diagnosed at a tertiary care pediatric weight management clinic. | 2018 | Details |
| A14407 | 29425212 | PLoS One | Insulin resistance in lean and overweight non-diabetic Caucasian adults: Study of its relationship with liver triglyceride content, waist circumference and BMI. | 2018 | Details |
| A14408 | 29424123 | J Gastroenterol Hepatol | Mouse models of non-alcoholic steatohepatitis: A reflection on recent literature. | 2018 | Details |
| A14415 | 29417009 | J Family Med Prim Care | Hepatobiliary dysfunction in Type-2 diabetes mellitus. | 2022 | Details |
| A14423 | 29413998 | Curr Opin Pharmacol | Lipid-lowering treatment in peripheral artery disease. | 2018 | Details |
| A14425 | 29412830 | Peptides | Glucagon receptor signaling in metabolic diseases. | 2018 | Details |
| A14426 | 29411334 | J Cell Commun Signal | Regulation and bioactivity of the CCN family of genes and proteins in obesity and diabetes. | 2018 | Details |
| A14457 | 29402657 | Diabetes Metab Syndr | Nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus and its association with cardiovascular disease. | 2018 | Details |
| A14465 | 29399277 | World J Hepatol | Fatty liver disease, an emerging etiology of hepatocellular carcinoma in Argentina. | 2018 | Details |
| A14471 | 29398414 | Dig Liver Dis | Nonalcoholic fatty liver disease as a sentinel marker for the development of diabetes mellitus in non-obese subjects. | 2017 | Details |
| A14472 | 29398327 | J Diabetes Complications | Differing clinical phenotype for higher alanine-aminotransferase (ALT) compared with high-risk NAFLD fibrosis score in type 2 diabetes mellitus. | 2017 | Details |
| A14475 | 29396131 | Dig Liver Dis | Donor PNPLA3 rs738409 genotype is a risk factor for graft steatosis. A post-transplant biopsy-based study. | 2018 | Details |
| A14483 | 29390925 | Crit Rev Clin Lab Sci | Diagnostic criteria and contributors to Gilbert's syndrome. | 2018 | Details |
| A14494 | 29382663 | Diabetes | Long Noncoding RNA lncSHGL Recruits hnRNPA1 to Suppress Hepatic Gluconeogenesis and Lipogenesis. | 2018 | Details |
| A14500 | 29379801 | J Diabetes Res | Quercetin Improves Glucose and Lipid Metabolism of Diabetic Rats: Involvement of Akt Signaling and SIRT1. | 2017 | Details |
| A14504 | 29378152 | Can J Physiol Pharmacol | Beneficial effects of N-acetylcysteine on hepatic oxidative stress in streptozotocin-induced diabetic rats. | 2018 | Details |
| A14508 | 29377201 | Ann N Y Acad Sci | Cardiometabolic risk in obese children. | 2018 | Details |
| A14510 | 29376471 | Adipocyte | Emerging roles of SGLT2 inhibitors in obesity and insulin resistance: Focus on fat browning and macrophage polarization. | 2018 | Details |
| A14517 | 29372507 | Hepatol Int | Repeated liver stiffness measurement compared with paired liver biopsy in patients with non-alcoholic fatty liver disease. | 2018 | Details |
| A14537 | 29363914 | Pol J Pathol | Expression of resistin in the liver of patients with non-alcoholic fatty liver disease. | 2018 | Details |
| A14538 | 29363154 | J Ultrasound Med | Nonalcoholic Fatty Liver Is Associated With Further Left Ventricular Abnormalities in Patients With Type 2 Diabetes Mellitus: A 3-Dimensional Speckle-Tracking Study. | 2018 | Details |
| A14539 | 29363040 | Drugs | Semaglutide: First Global Approval. | 2018 | Details |
| A14550 | 29358945 | PPAR Res | Peroxisome Proliferator-Activated Receptors Associated with Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A14551 | 29358469 | Diabetes Care | Nonalcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: A Meta-analysis. | 2018 | Details |
| A14566 | 29351115 | Eur J Gastroenterol Hepatol | Synergistic increase in cardiovascular risk in diabetes mellitus with nonalcoholic fatty liver disease: a meta-analysis. | 2018 | Details |
| A14573 | 29348103 | Pak J Pharm Sci | Prevalence of non alcoholic fatty liver and Non alcoholic Steatohepatitis in Peshawar Cantonment, Khyber Pakhtunkhwa, Pakistan. | 2018 | Details |
| A14576 | 29344336 | Ther Adv Endocrinol Metab | Treating nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus: a review of efficacy and safety. | 2017 | Details |
| A14582 | 29341349 | Pathol Int | Peroxiredoxin 4 (PRDX4): Its critical in vivo roles in animal models of metabolic syndrome ranging from atherosclerosis to nonalcoholic fatty liver disease. | 2018 | Details |
| A14590 | 29335916 | Sleep Breath | Association between obstructive sleep apnea and non-alcoholic fatty liver disease: a systematic review and meta-analysis. | 2018 | Details |
| A14594 | 29334743 | Vnitr Lek | [Adiponectin in patients with metabolic syndrome and diseases of the liver, bile ducts and pancreas]. | 2018 | Details |
| A14596 | 29333610 | Aliment Pharmacol Ther | Clinical features and treatment of nonalcoholic fatty liver disease across the Asia Pacific region-the GO ASIA initiative. | 2018 | Details |
| A14605 | 29327078 | Cell Mol Life Sci | The role of the thioredoxin/thioredoxin reductase system in the metabolic syndrome: towards a possible prognostic marker? | 2018 | Details |
| A14616 | 29322544 | Aliment Pharmacol Ther | Role of bisphenol A as environmental factor in the promotion of non-alcoholic fatty liver disease: in vitro and clinical study. | 2018 | Details |
| A14617 | 29322175 | JAMA Dermatol | Association of Psoriasis With Comorbidity Development in Children With Psoriasis. | 2018 | Details |
| A14619 | 29321441 | Intern Med | Diabetes Mellitus Prevents an Improvement in the Serum Albumin Level During Interferon-free Sofosbuvir-based Therapy for Chronic Hepatitis C Patients: A Multi-institutional Joint Study. | 2018 | Details |
| A14624 | 29318450 | Hepatol Int | The utility of noninvasive scores in assessing the prevalence of nonalcoholic fatty liver disease and advanced fibrosis in type 1 diabetic patients. | 2018 | Details |
| A14655 | 29307797 | Exp Mol Pathol | Alcoholic hepatitis versus non-alcoholic steatohepatitis: Levels of expression of some proteins involved in tumorigenesis. | 2018 | Details |
| A14657 | 29307656 | Obes Res Clin Pract | Metabolically healthy obesity without fatty liver and risk of incident type 2 diabetes: A meta-analysis of prospective cohort studies. | 2018 | Details |
| A14659 | 29304731 | BMC Gastroenterol | Safety, tolerability and pharmacodynamics of apical sodium-dependent bile acid transporter inhibition with volixibat in healthy adults and patients with type 2 diabetes mellitus: a randomised placebo-controlled trial. | 2018 | Details |
| A14668 | 29295869 | Endocr Connect | Macrophage activation marker sCD163 correlates with accelerated lipolysis following LPS exposure: a human-randomised clinical trial. | 2018 | Details |
| A14670 | 29294265 | Postepy Biochem | [The role of NOD-like receptors (NLRs) in the pathogenesis of metabolic diseases]. | 2019 | Details |
| A14671 | 29294263 | Postepy Biochem | [NAFLD pathogenesis in the light of recent research]. | 2019 | Details |
| A14692 | 29287685 | Pharmacol Res | Medicinal plants and bioactive natural compounds in the treatment of non-alcoholic fatty liver disease: A clinical review. | 2017 | Details |
| A14698 | 29286050 | Nat Rev Endocrinol | Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus. | 2017 | Details |
| A14699 | 29285942 | Orv Hetil | [Non-alcoholic fatty liver disease, as a component of the metabolic syndrome, and its causal correlations with other extrahepatic diseases]. | 2017 | Details |
| A14700 | 29281159 | Eur J Neurol | Non-alcoholic fatty liver disease is associated with stroke severity and progression of brainstem infarctions. | 2018 | Details |
| A14704 | 29280273 | J Intern Med | Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver. | 2017 | Details |
| A14712 | 29276410 | Clin Epidemiol | Clinical course of nonalcoholic fatty liver disease: an assessment of severity, progression, and outcomes. | 2017 | Details |
| A14750 | 29255745 | GE Port J Gastroenterol | Diagnostic Accuracy of Controlled Attenuation Parameter for Detecting Hepatic Steatosis in Patients with Chronic Liver Disease. | 2016 | Details |
| A14754 | 29254185 | Oncotarget | Hepatoprotective potential of isoquercitrin against type 2 diabetes-induced hepatic injury in rats. | 2017 | Details |
| A14766 | 29249016 | Hum Cell | Therapeutic activity of plant-derived alkaloid conophylline on metabolic syndrome and neurodegenerative disease models. | 2017 | Details |
| A14770 | 29247558 | Diabet Med | European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD) and European Association for the Study of Obesity (EASO) clinical practice recommendations for the management of non-alcoholic fatty liver disease: evaluation of their application in people with Type 2 diabetes. | 2018 | Details |
| A14782 | 29235014 | Obes Surg | Increased Bile Acid Signals After Duodenal-Jejunal Bypass Improve Non-alcoholic Steatohepatitis (NASH) in a Rodent Model of Diet-Induced NASH. | 2018 | Details |
| A14784 | 29234634 | Liver Cancer | Association of Serum Ferritin with Diabetes and Alcohol in Patients with Non-Viral Liver Disease-Related Hepatocellular Carcinoma. | 2017 | Details |
| A14798 | 29226116 | Can J Gastroenterol Hepatol | Alcohol Consumption in Diabetic Patients with Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A14808 | 29223443 | Clin Gastroenterol Hepatol | Response to Pioglitazone in Patients With Nonalcoholic Steatohepatitis With vs Without Type 2 Diabetes. | 2017 | Details |
| A14818 | 29221790 | Metabolism | FAM3 gene family: A promising therapeutical target for NAFLD and type 2 diabetes. | 2017 | Details |
| A14826 | 29216638 | Cell Physiol Biochem | MicroRNA-122 Inhibits Lipid Droplet Formation and Hepatic Triglyceride Accumulation via Yin Yang 1. | 2017 | Details |
| A14839 | 29209995 | Diabetes Ther | Early Clinical Expressions of Insulin Resistance: The Real Enemy to Look For. | 2017 | Details |
| A14840 | 29209440 | EPMA J | Efficacy of Fenugreek-based bionanocomposite on renal dysfunction and endogenous intoxication in high-calorie diet-induced obesity rat model-comparative study. | 2017 | Details |
| A14867 | 29199410 | Diabetes Metab J | Non-Alcoholic Fatty Liver Disease: The Emerging Burden in Cardiometabolic and Renal Diseases. | 2017 | Details |
| A14870 | 29197664 | Biochim Biophys Acta Mol Basis Dis | Emerging metabolic risk factors in hepatocellular carcinoma and their influence on the liver microenvironment. | 2017 | Details |
| A14876 | 29195686 | Trends Endocrinol Metab | Role of Bile Acids in Metabolic Control. | 2017 | Details |
| A14889 | 29189999 | J Endocrinol Invest | NAFLD/NASH in patients with type 2 diabetes and related treatment options. | 2017 | Details |
| A14893 | 29188065 | BMJ Open Diabetes Res Care | High circulating plasma dipeptidyl peptidase- 4 levels in non-obese Asian Indians with type 2 diabetes correlate with fasting insulin and LDL-C levels, triceps skinfolds, total intra-abdominal adipose tissue volume and presence of diabetes: a case-control study. | 2017 | Details |
| A14898 | 29184449 | HIV AIDS (Auckl) | Diabetes, metabolic syndrome and dyslipidemia in people living with HIV in Africa: re-emerging challenges not to be forgotten. | 2017 | Details |
| A14910 | 29177105 | J Clin Cell Immunol | Investigating Molecular Connections of Non-alcoholic Fatty Liver Disease with Associated Pathological Conditions in West Virginia for Biomarker Analysis. | 2017 | Details |
| A14913 | 29175669 | J Nutr Biochem | Euterpe oleracea Mart. (açaí) seed extract associated with exercise training reduces hepatic steatosis in type 2 diabetic male rats. | 2017 | Details |
| A14925 | 29170905 | Endocrine | Irisin in metabolic diseases. | 2017 | Details |
| A14934 | 29167212 | Diabetes Care | Cardiovascular Disease, Cancer, and Mortality Among People With Type 2 Diabetes and Alcoholic or Nonalcoholic Fatty Liver Disease Hospital Admission. | 2017 | Details |
| A14935 | 29167192 | J Investig Med | Cytokeratin-18 and enhanced liver fibrosis scores in type 1 and type 2 diabetes and effects of two different insulins. | 2017 | Details |
| A14945 | 29162389 | J Hepatol | Is cryptogenic cirrhosis different from NASH cirrhosis? | 2017 | Details |
| A14947 | 29161233 | J Basic Clin Physiol Pharmacol | Swimming, but not vitamin E, ameliorates prothrombotic state and hypofibrinolysis in a rat model of nonalcoholic fatty liver disease. | 2018 | Details |
| A14948 | 29160087 | Antioxid Redox Signal | Glyoxalase 1 Modulation in Obesity and Diabetes. | 2018 | Details |
| A14949 | 29159396 | JAMA Neurol | Association of Nonalcoholic Fatty Liver Disease With Lower Brain Volume in Healthy Middle-aged Adults in the Framingham Study. | 2018 | Details |
| A14952 | 29158770 | Nutr Metab (Lond) | Does the enterolactone (ENL) affect fatty acid transporters and lipid metabolism in liver? | 2017 | Details |
| A14973 | 29150490 | Gut | Gut roundtable meeting paper: selected recent advances in hepatocellular carcinoma. | 2017 | Details |
| A14979 | 29145775 | Trop Doct | Factors predicting non-alcoholic steatohepatitis (NASH) and advanced fibrosis in patients with non-alcoholic fatty liver disease (NAFLD). | 2017 | Details |
| A14993 | 29133343 | Diabetes Care | Clinical and Histologic Characterization of Nonalcoholic Steatohepatitis in African American Patients. | 2017 | Details |
| A14994 | 29132522 | Prim Care | Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A15004 | 29128158 | Trends Endocrinol Metab | Mitogen-Activated Protein Kinase Regulation in Hepatic Metabolism. | 2017 | Details |
| A15009 | 29128060 | Clin Liver Dis | Risk Factors for the Development of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Including Genetics. | 2017 | Details |
| A15012 | 29128057 | Clin Liver Dis | Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma. | 2018 | Details |
| A15015 | 29128054 | Clin Liver Dis | The Role of Nonalcoholic Fatty Liver Disease on Cardiovascular Manifestations and Outcomes. | 2017 | Details |
| A15039 | 29122390 | J Hepatol | Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence? | 2017 | Details |
| A15055 | 29093809 | F1000Res | Gender differences in the prevalence of nonalcoholic fatty liver disease in the Northeast of Thailand: A population-based cross-sectional study. | 2017 | Details |
| A15062 | 29113741 | Cytokine | Low serum CTRP3 levels are associated with nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus. | 2017 | Details |
| A15067 | 29111276 | Diabetes Res Clin Pract | The persistence of fatty liver has a differential impact on the development of diabetes: The Kangbuk Samsung Health Study. | 2017 | Details |
| A15070 | 29109457 | Sci Rep | Non-alcoholic fatty liver disease is an influencing factor for the association of SHBG with metabolic syndrome in diabetes patients. | 2017 | Details |
| A15071 | 29109303 | Clin Sci (Lond) | Insulin resistance and reduced metabolic flexibility: cause or consequence of NAFLD? | 2017 | Details |
| A15087 | 29104004 | Surg Obes Relat Dis | Nonalcoholic fatty liver disease in patients with different baseline glucose status undergoing bariatric surgery: analysis of intraoperative liver biopsies and literature review. | 2017 | Details |
| A15098 | 29097288 | Diabetes Res Clin Pract | Trend over time in hepatic fibrosis score in a cohort of type 2 diabetes patients. | 2017 | Details |